[The prevention of anthracycline-induced cardiomyopathy with a chelating agent (dexrazoxane = ICRF-187)].
Sauer
H
H
D000293:Adolescent; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000517:prevention & control*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002614:Chelating Agents / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D011929:Razoxane / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D002317:Cardiovascular Agents; D002614:Chelating Agents; D011929:Razoxane
Prävention der Anthrazyklinkardiomyopathie mit einem Chelatbildner (Dexrazoxane = ICRF-187).